Drug
IBI3033
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_1
3
100%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Not yet recruiting3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 13 (100.0%)
Trials by Status
not_yet_recruiting3100%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingphase_1
A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis
NCT07549984
not_yet_recruitingphase_1
A Mutiple-dose Study of IBI3033 in Healthy Participants
NCT07456839
not_yet_recruitingphase_1
A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants
NCT07311226
Clinical Trials (3)
Showing 3 of 3 trials
NCT07549984Phase 1
A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis
NCT07456839Phase 1
A Mutiple-dose Study of IBI3033 in Healthy Participants
NCT07311226Phase 1
A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3